tb500

TB-500 is a shortened version of thymosin beta-4, a peptide discussed for its possible role in tissue repair. Most of the evidence described is from animal studies, and its effects in people remain uncertain without conclusive clinical trials. 1

• 1. Wound healing and repair: Thymosin beta-4 is described as potentially supporting wound healing by promoting cell growth and infiltration, stem-cell proliferation, and extracellular-matrix formation. 2
• 2. Evidence base: Animal studies report improved wound healing, while human reports of benefit are anecdotal; without clinical trials, whether or how it works in people is unknown. 3
• 3. Difference from BPC-157: BPC-157 is framed mainly as promoting angiogenesis—new blood-vessel growth—whereas thymosin beta-4 is described as supporting cellular processes involved in tissue repair. 4
• 4. Caution: Treat TB-500’s safety and effectiveness as unconfirmed; the discussion emphasizes that clinical evidence is lacking. 5